TGFBR3 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "TGFBR3" in English language version.

refsWebsite

Global rank English rank

14nih.gov

4^th place

8doi.org

2^nd place

2ensembl.org

1,626^th place

1,007^th place

2semanticscholar.org

11^th place

8^th place

1harvard.edu

18^th place

17^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Andres JL, Stanley K, Cheifetz S, Massagué J (December 1989). "Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta". The Journal of Cell Biology. 109 (6 Pt 1): 3137–3145. doi:10.1083/jcb.109.6.3137. PMC 2115961. PMID 2592419.
Andres JL, DeFalcis D, Noda M, Massagué J (March 1992). "Binding of two growth factor families to separate domains of the proteoglycan betaglycan". The Journal of Biological Chemistry. 267 (9): 5927–5930. doi:10.1016/S0021-9258(18)42643-9. PMID 1556106.
Vander Ark A, Cao J, Li X (December 2018). "TGF-β receptors: In and beyond TGF-β signaling". Cellular Signalling. 52: 112–120. doi:10.1016/j.cellsig.2018.09.002. PMID 30184463. S2CID 52164499.
Batlle E, Massagué J (April 2019). "Transforming Growth Factor-β Signaling in Immunity and Cancer". Immunity. 50 (4): 924–940. doi:10.1016/j.immuni.2019.03.024. PMC 7507121. PMID 30995507.
Velasco-Loyden G, Arribas J, López-Casillas F (February 2004). "The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1". The Journal of Biological Chemistry. 279 (9): 7721–7733. doi:10.1074/jbc.m306499200. PMID 14672946.
Mendoza V, Vilchis-Landeros MM, Mendoza-Hernández G, Huang T, Villarreal MM, Hinck AP, et al. (December 2009). "Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor". Biochemistry. 48 (49): 11755–11765. doi:10.1021/bi901528w. PMC 2796082. PMID 19842711.
Chen Y, Di C, Zhang X, Wang J, Wang F, Yan JF, et al. (March 2020). "Transforming growth factor β signaling pathway: A promising therapeutic target for cancer". Journal of Cellular Physiology. 235 (3): 1903–1914. doi:10.1002/jcp.29108. PMID 31332789. S2CID 198172452.
Boivin WA, Shackleford M, Vanden Hoek A, Zhao H, Hackett TL, Knight DA, et al. (2012-03-30). "Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1". PLOS ONE. 7 (3) e33163. Bibcode:2012PLoSO...733163B. doi:10.1371/journal.pone.0033163. PMC 3316562. PMID 22479366.

ensembl.org (Global: 1,626^th place; English: 1,007^th place)

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000069702 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000029287 – Ensembl, May 2017

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Boivin WA, Shackleford M, Vanden Hoek A, Zhao H, Hackett TL, Knight DA, et al. (2012-03-30). "Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1". PLOS ONE. 7 (3) e33163. Bibcode:2012PLoSO...733163B. doi:10.1371/journal.pone.0033163. PMC 3316562. PMID 22479366.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Andres JL, Stanley K, Cheifetz S, Massagué J (December 1989). "Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta". The Journal of Cell Biology. 109 (6 Pt 1): 3137–3145. doi:10.1083/jcb.109.6.3137. PMC 2115961. PMID 2592419.
Andres JL, DeFalcis D, Noda M, Massagué J (March 1992). "Binding of two growth factor families to separate domains of the proteoglycan betaglycan". The Journal of Biological Chemistry. 267 (9): 5927–5930. doi:10.1016/S0021-9258(18)42643-9. PMID 1556106.
Vander Ark A, Cao J, Li X (December 2018). "TGF-β receptors: In and beyond TGF-β signaling". Cellular Signalling. 52: 112–120. doi:10.1016/j.cellsig.2018.09.002. PMID 30184463. S2CID 52164499.
Batlle E, Massagué J (April 2019). "Transforming Growth Factor-β Signaling in Immunity and Cancer". Immunity. 50 (4): 924–940. doi:10.1016/j.immuni.2019.03.024. PMC 7507121. PMID 30995507.
Velasco-Loyden G, Arribas J, López-Casillas F (February 2004). "The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1". The Journal of Biological Chemistry. 279 (9): 7721–7733. doi:10.1074/jbc.m306499200. PMID 14672946.
Mendoza V, Vilchis-Landeros MM, Mendoza-Hernández G, Huang T, Villarreal MM, Hinck AP, et al. (December 2009). "Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor". Biochemistry. 48 (49): 11755–11765. doi:10.1021/bi901528w. PMC 2796082. PMID 19842711.
Chen Y, Di C, Zhang X, Wang J, Wang F, Yan JF, et al. (March 2020). "Transforming growth factor β signaling pathway: A promising therapeutic target for cancer". Journal of Cellular Physiology. 235 (3): 1903–1914. doi:10.1002/jcp.29108. PMID 31332789. S2CID 198172452.
Boivin WA, Shackleford M, Vanden Hoek A, Zhao H, Hackett TL, Knight DA, et al. (2012-03-30). "Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1". PLOS ONE. 7 (3) e33163. Bibcode:2012PLoSO...733163B. doi:10.1371/journal.pone.0033163. PMC 3316562. PMID 22479366.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Andres JL, Stanley K, Cheifetz S, Massagué J (December 1989). "Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta". The Journal of Cell Biology. 109 (6 Pt 1): 3137–3145. doi:10.1083/jcb.109.6.3137. PMC 2115961. PMID 2592419.
Batlle E, Massagué J (April 2019). "Transforming Growth Factor-β Signaling in Immunity and Cancer". Immunity. 50 (4): 924–940. doi:10.1016/j.immuni.2019.03.024. PMC 7507121. PMID 30995507.
Mendoza V, Vilchis-Landeros MM, Mendoza-Hernández G, Huang T, Villarreal MM, Hinck AP, et al. (December 2009). "Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor". Biochemistry. 48 (49): 11755–11765. doi:10.1021/bi901528w. PMC 2796082. PMID 19842711.
Boivin WA, Shackleford M, Vanden Hoek A, Zhao H, Hackett TL, Knight DA, et al. (2012-03-30). "Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1". PLOS ONE. 7 (3) e33163. Bibcode:2012PLoSO...733163B. doi:10.1371/journal.pone.0033163. PMC 3316562. PMID 22479366.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Vander Ark A, Cao J, Li X (December 2018). "TGF-β receptors: In and beyond TGF-β signaling". Cellular Signalling. 52: 112–120. doi:10.1016/j.cellsig.2018.09.002. PMID 30184463. S2CID 52164499.
Chen Y, Di C, Zhang X, Wang J, Wang F, Yan JF, et al. (March 2020). "Transforming growth factor β signaling pathway: A promising therapeutic target for cancer". Journal of Cellular Physiology. 235 (3): 1903–1914. doi:10.1002/jcp.29108. PMID 31332789. S2CID 198172452.

TGFBR3 (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)

ensembl.org (Global: 1,626th place; English: 1,007th place)